GeneThera Inc (GTHR)
OTHER OTC:GTHR
US Market
Holding GTHR?
Track your performance easily

GeneThera (GTHR) Financial Statements

1 Followers

GeneThera Financial Overview

GeneThera's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; GeneThera is scheduled to report earnings on March 28, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -125.02K$ -147.94K$ -132.19K$ -274.43K$ -242.22K
EBITDA$ -123.70K$ -146.62K$ -130.87K$ -273.11K$ -240.90K
Net Income Common Stockholders$ -125.57K$ -147.94K$ -132.75K$ -30.03K$ -243.87K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 1.32K$ 2.64K$ 3.96K$ 6.30K$ 7.62K
Total Debt$ 25.80K$ 90.30K$ 90.30K$ 90.30K$ 83.80K
Net Debt$ 25.80K$ 90.30K$ 90.30K$ 90.30K$ 83.80K
Total Liabilities$ 8.54M$ 8.42M$ 8.31M$ 8.18M$ 8.06M
Stockholders Equity$ -8.57M$ -8.44M$ -8.31M$ -8.17M$ -8.05M
Cash Flow-
Free Cash Flow$ 6.03K$ -5.01K$ -3.59K$ -9.90K$ -1.00
Operating Cash Flow$ 6.03K$ -5.01K$ -3.59K$ -9.90K$ -1.00
Investing Cash Flow-----
Financing Cash Flow$ -6.03K$ 5.01K$ 3.59K$ 9.90K$ -2.65K
Currency in USD

GeneThera Earnings and Revenue History

GeneThera Debt to Assets

GeneThera Cash Flow

GeneThera Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis